CG Oncology, Inc. (CGON) shares rallied 5.5% in the last trading session to close at $37.72. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 39.9% gain over the past four weeks.The sudden price rise can be attributed to growing investor optimism related to the company’s efforts in developing its investigational candidate, cretostimogene grenadenorepvec, which is being evaluated both as a monotherapy and in co ...